In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B

[ad_1]

Abridge, an AI startup automating medical notes, has secured a $300 million Series E at a $5.3 billion valuation, according to the Wall Street Journal.  The round, led by Andreessen Horowitz with participation from Khosla Ventures, follows the company’s $250 million February fundraise at a $2.75 billion valuation.

[ad_2]

Source link